Conmed Target Price

Conmed (CNMD) currently reports a target price of $38. Use the charts on this page to explore Conmed's target price history and peer comparisons.

Analysts' average 12-month price target for Conmed is $38, about 23.9% downside from the current share price of $49.26. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $38, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Conmed, and consider following CNMD for alerts when major investors trade the stock.

Conmed is classified in the Healthcare sector. On target price, it currently shows $38. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CNMD with unrelated industries.